Head and Neck Cancer News
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
Patients with cancer experienced symptoms of PTSD during the first year of the COVID-19 pandemic, a French study suggests.
Oropharyngeal cancer patients who have discordant p16 and HPV status have worse prognosis than patients who have p16+/HPV+ disease, a study suggests.
Increasing social vulnerability is associated with significant decreases in surveillance and survival time among pediatric patients with head and neck cancers.
Among patients with head and neck cancer, smoking cessation for more than 10 years is associated with reduced overall mortality and cancer-specific mortality.
Adding docetaxel to radiation improves outcomes for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase 2/3 trial suggests.
Larotrectinib prolongs survival when compared with non-TRK inhibitor standard care in adults with TRK fusion-positive cancers, a study suggests.
Centers that perform comprehensive cancer screening in a single appointment may enable earlier cancer diagnosis.
Researchers compared a turmeric mouthwash to benzydamine mouthwash in patients with head and neck cancer.
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Cancer patients have an increased risk of suicide when compared with the general population in the United States, a study suggests.
Compared with the general population, survivors of childhood and adolescent cancers have an increased risk of 6 major psychiatric disorders.
Patients undergoing cancer surgery have an increased risk of suicide compared with the general population, a new study suggests.
Some oncology practices are less likely than others to adopt immunotherapies within 2 years of regulatory approval, a study suggests.
Many thyroid cancer survivors said they lacked understanding of their treatment before receiving it.
Outcomes were worse for Black patients than for White patients, despite similar access to care and socioeconomic status.
Recurrence of esthesioneuroblastoma with non-contiguous intracranial metastasis is possible 19 years after remission, a review suggests.
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Durvalumab plus IMRT proved no more effective than cetuximab plus IMRT in patients with treatment-naïve, locoregionally advanced head and neck squamous cell carcinoma.
COVID-19 vaccination is safe for cancer patients receiving immune checkpoint inhibitors and should not interrupt therapy, according to researchers.